Aveanna Healthcare Holdings Inc. (AVAH)
USD 4.42
(4.62%)
USD 4.42
(4.62%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 8.07 Million USD | 334.83% |
| 2022 | 26.3 Million USD | -72.59% |
| 2021 | 95.96 Million USD | 17.1% |
| 2020 | 81.95 Million USD | 110.38% |
| 2019 | 38.95 Million USD | -0.2% |
| 2018 | 39.03 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 26.13 Million USD | -19.18% |
| 2024 Q2 | 39.2 Million USD | 50.04% |
| 2023 Q1 | 17.63 Million USD | 1103.36% |
| 2023 FY | 114.38 Million USD | 334.83% |
| 2023 Q4 | 32.33 Million USD | 142.35% |
| 2023 Q3 | -76.35 Million USD | -303.65% |
| 2023 Q2 | 37.49 Million USD | 112.55% |
| 2022 Q2 | 22.68 Million USD | 64.67% |
| 2022 Q1 | 13.77 Million USD | 112.19% |
| 2022 Q4 | -1.75 Million USD | -136.72% |
| 2022 FY | 26.3 Million USD | -72.59% |
| 2022 Q3 | 4.78 Million USD | -78.9% |
| 2021 Q4 | -113.04 Million USD | -716.17% |
| 2021 FY | 95.96 Million USD | 17.1% |
| 2021 Q3 | 18.34 Million USD | -39.44% |
| 2021 Q1 | 28.29 Million USD | 59.63% |
| 2021 Q2 | 30.29 Million USD | 7.06% |
| 2020 FY | 81.95 Million USD | 110.38% |
| 2020 Q4 | 17.72 Million USD | 37.66% |
| 2020 Q3 | 12.87 Million USD | 124.78% |
| 2020 Q2 | -51.95 Million USD | -390.8% |
| 2020 Q1 | 17.86 Million USD | 0.0% |
| 2019 FY | 38.95 Million USD | -0.2% |
| 2018 FY | 39.03 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 98.407% |
| Addus HomeCare Corporation | 90.95 Million USD | 91.125% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | 14.879% |
| Amedisys, Inc. | 156.39 Million USD | 94.839% |
| American Oncology Network, Inc. | -49.15 Million USD | 116.422% |
| Astrana Health, Inc. | 84.61 Million USD | 90.46% |
| IMAC Holdings, Inc. | -6.37 Million USD | 226.61% |
| biote Corp. | 28.65 Million USD | 71.832% |
| Cryo-Cell International, Inc. | -12.3 Million USD | 165.605% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 92.838% |
| COMPASS Pathways plc | -136.91 Million USD | 105.895% |
| DocGo Inc. | 15.05 Million USD | 46.383% |
| The Ensign Group, Inc. | 255.36 Million USD | 96.839% |
| Healthcare Services Group, Inc. | 62.35 Million USD | 87.055% |
| InnovAge Holding Corp. | -23.18 Million USD | 134.823% |
| Assure Holdings Corp. | -20.08 Million USD | 140.195% |
| The Joint Corp. | -2.07 Million USD | 489.371% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 104.268% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 151.402% |
| ModivCare Inc. | -139.94 Million USD | 105.768% |
| NewGenIvf Group Limited | 42.24 Thousand USD | -19008.944% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | 194.374% |
| Option Care Health, Inc. | 314.59 Million USD | 97.434% |
| P3 Health Partners Inc. | -167.86 Million USD | 104.809% |
| P3 Health Partners Inc. | -167.86 Million USD | 104.809% |
| The Pennant Group, Inc. | 25.16 Million USD | 67.929% |
| Surgery Partners, Inc. | 328 Million USD | 97.539% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | 379.54% |
| Talkspace, Inc. | -23.2 Million USD | 134.78% |
| Talkspace, Inc. | -23.2 Million USD | 134.78% |
| The Oncology Institute, Inc. | -77.01 Million USD | 110.481% |
| The Oncology Institute, Inc. | -77.01 Million USD | 110.481% |